Court Dismisses Promega's Case Against Applied Biosystems And Roche
"We are pleased with the court's ruling," said Catherine M. Burzik, President of Applied Biosystems. "Today's ruling upholds our position that there were no valid claims to Promega's case."
This is the Court's final decision in this case, but is subject to an appeal by Promega. Promega's case, filed under the federal False Claims Act, was first dismissed in June 2004, when the Court determined that Promega had failed to state a complaint upon which relief could be granted. Promega originally filed this case on April 10, 2000.
Other news from the department business & finance
Most read news
More news from our other portals
See the theme worlds for related content
Topic World PCR
This groundbreaking and highly versatile molecular technique of PCR allows us to amplify tiny amounts of genetic material on a large scale and analyze them in detail. Whether in medical diagnostics, forensic DNA analysis or research into genetic diseases - PCR is an indispensable tool that gives us deep insights into the world of DNA. Immerse yourself in the fascinating world of the polymerase chain reaction (PCR)!
Topic World PCR
This groundbreaking and highly versatile molecular technique of PCR allows us to amplify tiny amounts of genetic material on a large scale and analyze them in detail. Whether in medical diagnostics, forensic DNA analysis or research into genetic diseases - PCR is an indispensable tool that gives us deep insights into the world of DNA. Immerse yourself in the fascinating world of the polymerase chain reaction (PCR)!